Mountain View, CA, United States of America

Aclara Biosciences, Inc.


USPTO Granted Patents = 59

% Expired Patents = 13.6

Forward Citations = 8,651

Loading Chart...
Loading Chart...

56 inventors (with patents filed for the assignee):

goldMedal Sharat Singh (22 out of 62 patents)

silverMedal Torleif Ove Bjornson (12 out of 20 patents)

bronzeMedal Herbert H Hooper (9 out of 13 patents)

4.  Travis Boone (7 out of 7 patents)

5.  David S Soane (7 out of 80 patents)

6.  Ahmed Chenna (6 out of 9 patents)

7.  Ian Gibbons (6 out of 108 patents)

8.  Tracy J Matray (6 out of 15 patents)

9.  Zoya M Soane (6 out of 12 patents)

10.  Alexander P Sassi (6 out of 11 patents)

11.  Kevin Albert Maher (5 out of 63 patents)

12.  Stephen J Williams (5 out of 6 patents)

13.  Edwin F Ullman (4 out of 199 patents)

14.  Timothy F Smith (4 out of 4 patents)

15.  Randy M McCormick (4 out of 12 patents)


Core Competencies:
Microfluidic Devices
Electrophoretic Analysis
Multiplexed Assays
Optical Readings
Oligonucleotide Probes
Bioanalytical Methods
Fluorescent Detection
Sample Handling
Nucleic Acid Detection
Capillary Electrokinesis
Microchannel Structures
Dynamic Coating

59 patents:

Aclara Biosciences, Inc., based in Mountain View, CA, specializes in advanced microfluidics technology, focusing on the development of innovative microfluidic devices. The company is dedicated to enhancing bioanalytical methods through its expertise in electrophoretic analysis, multiplexed assays, and optical readings. Aclara's work with oligonucleotide probes and fluorescent detection techniques positions it at the forefront of precision diagnostics and sample handling solutions, catering to the evolving needs of the life sciences sector.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

59 Patents

#56 in Mountain View, CA

#1,425 in California

#6,069 in US

#12,226 in the World

Mountain View, CA (US)
Mountain View, CA, United States of America
Forward Citations = 8,651

56 inventors:

Please report any incorrect information to [email protected]
Loading…